Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001494650-22-000006
Filing Date
2022-01-12
Accepted
2022-01-12 16:02:39
Documents
1
Period of Report
2022-01-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164202134380026.html 4  
1 FORM 4 wf-form4_164202134380026.xml 4 8720
  Complete submission text file 0001494650-22-000006.txt   10095
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Issuer) CIK: 0001494650 (see all company filings)

EIN.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428
Business Address
Goldan Keith A. (Reporting) CIK: 0001495411 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38241 | Film No.: 22526635